Genfit
Short position disclosed on September 21, 2026.
1.10% of the capital sold short
2 disclosing funds
753 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
October 13, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Winton Capital Management Limited | 0.60% | new | September 21, 2026 | |
| Capital Fund Management | 0.50% | new | September 14, 2026 |
On the other side: the funds that hold Genfit Titelia
Get the moves on Genfit by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 22, 2014 | Oxford Asset Management LLP | 0.53% | April 10, 2015 |
| October 14, 2014 | Bogle Investment Management, L.P. | 0.65% | November 12, 2014 |
| October 13, 2014 | Bogle Investment Management, L.P. | 0.53% | November 12, 2014 |
Download 753 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Viridien 8.08% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Genfit, source AMF, data as at September 21, 2026, https://www.quivad.com/action/genfit?page=16